Shanxi C&Y Pharmaceutical Group (300254.SZ) announced on June 3rd that the restricted stock incentive plan for 2024 has established the conditions for granting restricted stock rights, and agreed to designate the grant date as June 3, 2024. A total of 7.05 million restricted stocks will be granted to 50 incentive recipients who meet the granting conditions at a grant price of 4.73 yuan per share.
仟源医药(300254.SZ)：向50名激励对象授予705万股限制性股票
Shanxi C&Y Pharmaceutical Group (300254.SZ) granted 7.05 million restricted stocks to 50 incentive targets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.